MFT
ALNY icon

Moisand Fitzgerald Tamayo’s Alnylam Pharmaceuticals ALNY Stock Holding History

Moisand Fitzgerald Tamayo’s Portfolio ALNY Stock Details ALNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-8
Closed -$1K – 404
2021
Q1 		$1K Hold
8
– – ﹤0.01% 321
2020
Q4 		$1K Hold
8
– – ﹤0.01% 317
2020
Q3 		$1K Hold
8
– – ﹤0.01% 296
2020
Q2 		$1K Buy
+8
New +$1.08K ﹤0.01% 282

Other funds holding ALNY

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Moisand Fitzgerald Tamayo's ALNY Position: Q2 2021 in Review

Moisand Fitzgerald Tamayo sold out of Alnylam Pharmaceuticals (ALNY) in Q2 2021, closing a stake of 8 shares — an estimated $1K sold.

Moisand Fitzgerald Tamayo first reported a position in ALNY in Q2 2020 and held it in 4 quarters. The position peaked at $1K in Q1 2021. 401 funds tracked by Wall St. Rank hold ALNY as of Q2 2021.

  • Moisand Fitzgerald Tamayo reported no remaining Alnylam Pharmaceuticals position as of Q2 2021 after selling out during the quarter.
  • Moisand Fitzgerald Tamayo sold 8 Alnylam Pharmaceuticals shares in Q2 2021, an estimated $1K.
  • Moisand Fitzgerald Tamayo first reported a position in Alnylam Pharmaceuticals in Q2 2020 and held it in 4 quarters.
  • Moisand Fitzgerald Tamayo's Alnylam Pharmaceuticals position peaked at $1K in Q1 2021.
  • 401 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q2 2021.

Based on Moisand Fitzgerald Tamayo's 13F filing for Q2 2021, filed 3 Aug 2021.